华通医药 (002758.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(华通医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2019年一季报2018年年报2018年三季报2018年中报2018年一季报2017年年报2017年三季报2017年中报2017年一季报
主要指标:
 营业收入(元) 413,945,156.041,522,689,101.481,127,155,022.59738,315,913.54389,938,743.311,369,098,128.171,012,152,941.23664,883,620.04325,886,388.70
 营业利润(元) 9,527,318.2242,244,826.4034,274,397.6625,109,221.818,816,277.9555,411,734.0244,257,414.9530,232,026.1912,526,272.08
 利润总额(元) 8,863,852.5941,259,719.0134,628,706.8225,050,455.788,786,347.0954,369,167.2944,310,430.1030,935,938.6413,043,409.54
 净利润(元) 6,513,073.6531,063,168.2924,956,499.9518,495,634.406,601,963.6439,860,411.9133,391,322.5823,466,872.7310,029,768.49
 归属于母公司股东的净利润(元) 7,736,954.4034,563,260.7627,546,398.2520,398,943.907,695,288.7442,063,816.2334,431,005.6123,865,524.6010,160,055.81
盈利能力:
 销售毛利率(%) 14.5914.6714.7114.3913.0713.8513.5413.1812.35
 销售净利率(%) 1.572.042.212.511.692.913.303.533.08
 净资产收益率(%) 1.265.684.543.411.34----
 总资产报酬率ROA(%) 1.174.393.532.441.05----
 投入资本回报率ROIC(%) 0.593.382.401.990.845.224.313.011.32
营运能力:
 存货周转率(次) 1.525.614.433.121.71----
 应收账款周转率(次) 1.134.793.462.421.11----
 总资产周转率(次) 0.301.120.860.580.34----
偿债能力:
 资产负债率(%) 57.4057.7755.8454.8852.3452.2450.5951.0648.05
 股东权益比率(%) 42.5642.1143.9945.3147.8147.8349.4048.8751.85
 已获利息倍数(倍) 2.243.234.005.103.579.4612.6715.5319.91
 流动比率 1.561.531.561.571.201.221.261.281.44
 速动比率 1.171.111.111.140.800.820.920.941.09
发展能力:
 营业收入增长率(%) 6.1611.2211.3611.0419.658.8310.4610.556.13
 营业利润增长率(%) 8.07-23.76-23.67-17.88-30.586.0618.8921.092.96
 税后利润增长率(%) 0.54-17.83-20.00-14.53-24.264.7515.2717.1310.04
 净资产增长率(%) 9.559.6512.1212.954.294.825.405.294.50
 总资产增长率(%) 23.0424.5425.9221.8313.1214.5519.4624.4620.39

前瞻产业研究院